Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Edward Tobinick, Robert N. Spengler, Tracey A. Ignatowski, Manar Wassel & Samantha Laborde. (2022) Rapid improvement in severe long COVID following perispinal etanercept. Current Medical Research and Opinion 38:12, pages 2013-2020.
Read now
Read now
Ian A Clark. (2020) Randomized controlled trial validating the use of perispinal etanercept to reduce post-stroke disability has wide-ranging implications. Expert Review of Neurotherapeutics 20:3, pages 203-205.
Read now
Read now
Stephen J. Ralph, Andrew Weissenberger, Ventzislav Bonev, Liam D. King, Mikaela D. Bonham, Samantha Ferguson, Ashley D. Smith, Adrienne A. Goodman-Jones & Anthony J. Espinet. (2020) Phase I/II parallel double-blind randomized controlled clinical trial of perispinal etanercept for chronic stroke: improved mobility and pain alleviation. Expert Opinion on Investigational Drugs 29:3, pages 311-326.
Read now
Read now
I A Clark & B Vissel. (2019) Neurodegenerative disease treatments by direct TNF reduction, SB623 cells, maraviroc and irisin and MCC950, from an inflammatory perspective – a Commentary. Expert Review of Neurotherapeutics 19:6, pages 535-543.
Read now
Read now